Evidence map›Paper›PMID 36963092›Full record

ArticlePLOS global public health2023

National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas.

Brendon L Neuen, Aminu K Bello, Adeera Levin, Meaghan Lunney, Mohamed A Osman, Feng Ye, Gloria E Ashuntantang, Ezequiel Bellorin-Font, Mohammed Benghanem Gharbi, Sara Davison and 32 more

Full text read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Brendon L NeuenThe George Institute for Global Health, University of New South Wales, Sydney, Australia.ORCID https://orcid.org/0000-0001-9276-8380
Aminu K BelloDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada.
Meaghan LunneyDepartment of Community Health Sciences, University of Calgary, Calgary, Canada.ORCID https://orcid.org/0000-0003-4954-0529
Mohamed A OsmanDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Feng YeDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Gloria E AshuntantangFaculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde, Yaounde, Cameroon.
Ezequiel Bellorin-FontDivision of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, Missouri, United States of America.
Mohammed Benghanem GharbiUrinary Tract Diseases Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca, Morocco.
Sara DavisonDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Mohammad GhnaimatNephrology Division, Department of Internal Medicine, The Specialty Hospital, Amman, Jordan.
Paul HardenOxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Vivekanand JhaGeorge Institute for Global Health India, New Delhi, India.ORCID https://orcid.org/0000-0002-8015-9470
Kamyar Kalantar-ZadehDivision of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California, United States of America.
Peter G KerrDepartment of Medicine, Monash University, Melbourne, Australia.
Scott KlarenbachDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Csaba P KovesdyUniversity of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Valerie LuyckxDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.
Shahrzad OssarehDivision of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
Jeffrey PerlDivision of Nephrology, St. Michael's Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Harun Ur RashidDepartment of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Eric RondeauIntensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France.
Emily J SeeDepartment of Intensive Care, Austin Health, Melbourne, Australia.
Syed SaadDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Laura SolaDialysis Unit, CASMU-IAMPP, Montevideo, Uruguay.
Irma TchokhonelidzeNephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia.ORCID https://orcid.org/0000-0003-2303-6631
Vladimir TesarDepartment of Nephrology, General University Hospital, Charles University, Prague, Czech Republic.
Kriang TungsangaDepartment of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.ORCID https://orcid.org/0000-0003-4990-9306
Rumeyza Turan KazanciogluDivision of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
Angela Yee-Moon WangDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.ORCID https://orcid.org/0000-0003-2508-7117
Chih-Wei YangKidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Alexander ZemchenkovDepartment of Internal Disease and Nephrology, North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia.ORCID https://orcid.org/0000-0002-4590-3380
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Kitty J JagerERA Registry, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-0444-8569
Fergus J CaskeyPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.
Vlado PerkovicThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Kailash K JindalDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Ikechi G OkpechiDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Canada.
John FeehallyUniversity of Leicester, Leicester, United Kingdom.
David C HarrisCentre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
David W JohnsonCentre for Kidney Disease Research, University of Queensland, Brisbane, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

National strategies for addressing chronic kidney disease (CKD) are crucial to improving kidney health. We sought to describe country-level variations in non-communicable disease (NCD) strategies and CKD-specific policies across different regions and income levels worldwide. The International Society of Nephrology Global Kidney Health Atlas (GKHA) was a multinational cross-sectional survey conducted between July and October 2018. Responses from key opinion leaders in each country regarding national NCD strategies, the presence and scope of CKD-specific policies, and government recognition of CKD as a health priority were described overall and according to region and income level. 160 countries participated in the GKHA survey, comprising 97.8% of the world's population. Seventy-four (47%) countries had an established national NCD strategy, and 53 (34%) countries reported the existence of CKD-specific policies, with substantial variation across regions and income levels. Where CKD-specific policies existed, non-dialysis CKD care was variably addressed. 79 (51%) countries identified government recognition of CKD as a health priority. Low- and low-middle income countries were less likely to have strategies and policies for addressing CKD and have governments which recognise it as a health priority. The existence of CKD-specific policies, and a national NCD strategy more broadly, varied substantially across different regions around the world but was overall suboptimal, with major discrepancies between the burden of CKD in many countries and governmental recognition of CKD as a health priority. Greater recognition of CKD within national health policy is critical to improving kidney healthcare globally.

Identifiers

PMID36963092
PMCPMC10021302

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read20
identifiers read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.